Tidal Investments LLC Invests $879,000 in Option Care Health, Inc. (NASDAQ:OPCH)

Tidal Investments LLC acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 37,881 shares of the company's stock, valued at approximately $879,000.

A number of other large investors have also recently made changes to their positions in the company. Barclays PLC lifted its holdings in shares of Option Care Health by 180.1% during the third quarter. Barclays PLC now owns 310,194 shares of the company's stock worth $9,708,000 after purchasing an additional 199,454 shares during the period. UMB Bank n.a. lifted its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after purchasing an additional 346 shares during the period. Blue Trust Inc. lifted its stake in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after acquiring an additional 681 shares during the period. KBC Group NV lifted its stake in shares of Option Care Health by 46.4% in the 4th quarter. KBC Group NV now owns 7,337 shares of the company's stock worth $170,000 after acquiring an additional 2,324 shares during the period. Finally, Pacer Advisors Inc. lifted its stake in shares of Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company's stock worth $591,000 after acquiring an additional 537 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Barrington Research restated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Wednesday, April 30th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. raised their price target on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Finally, JMP Securities reissued a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Price Performance

OPCH stock traded up $0.57 during trading on Friday, hitting $32.83. The stock had a trading volume of 1,258,347 shares, compared to its average volume of 1,864,720. The stock has a market cap of $5.38 billion, a price-to-earnings ratio of 27.59, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company's 50 day moving average price is $32.73 and its two-hundred day moving average price is $29.67. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the prior year, the company posted $0.26 EPS. The company's quarterly revenue was up 16.3% compared to the same quarter last year. On average, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.